Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -95,496 | -188,917 | -142,181 | -72,754 | -43,843 |
| Depreciation Amortization | 2,029 | 383 | 531 | 199 | 155 |
| Accounts receivable | -13,876 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 686 | 2,316 | -1,484 | 1,542 | 132 |
| Other Working Capital | 26,480 | 9,418 | 6,564 | 2,695 | -357 |
| Other Operating Activity | 2,064 | 29,947 | 26,696 | 19,779 | 30,424 |
| Operating Cash Flow | $-78,113 | $-146,853 | $-109,874 | $-48,539 | $-13,489 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -264,725 | 131,602 | -255,048 | N/A | N/A |
| PPE Investments | -2,169 | -224 | -26 | N/A | -92 |
| Purchase Sale Intangibles | -17,100 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 35,900 | -3,000 | 0 | -8,000 | 0 |
| Investing Cash Flow | $-230,994 | $128,378 | $-255,074 | $-8,000 | $-92 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 201,385 | 162,747 | 165,259 | 167,045 | N/A |
| Other Financing Activity | 1,906 | 1,250 | 642 | 130,075 | 29,977 |
| Financing Cash Flow | $203,291 | $163,997 | $165,901 | $297,120 | $29,977 |
| Beginning Cash Position | 230,784 | 85,262 | 284,309 | 43,728 | 27,332 |
| End Cash Position | 124,968 | 230,784 | 85,262 | 284,309 | 43,728 |
| Net Cash Flow | $-105,816 | $145,522 | $-199,047 | $240,581 | $16,396 |
| Free Cash Flow | |||||
| Operating Cash Flow | -78,113 | -146,853 | -109,874 | -48,539 | -13,489 |
| Capital Expenditure | -2,169 | -224 | -26 | N/A | -92 |
| Free Cash Flow | -80,282 | -147,077 | -109,900 | -48,539 | -13,581 |